论文信息 - The influence of KRAS and BRAF mutations on the efficacy of cetuximab‐based first‐line therapy of metastatic colorectal cancer: An analysis of the AIO KRK‐0104‐trial - 字舞流文

The influence of KRAS and BRAF mutations on the efficacy of cetuximab‐based first‐line therapy of metastatic colorectal cancer: An analysis of the AIO KRK‐0104‐trial

V. Heinemann | J. Neumann | T. Kirchner | A. Jung | R. Laubender | S. Stintzing | S. Boeck | D. Modest | C. Giessen | C. Schulz | M. Haas | N. Moosmann